GLP-1 medications are reshaping employee benefits, but coverage decisions are only part of the equation. As pharmacy spend rises and discontinuation rates remain high, HR and benefits leaders are under pressure to build strategies that actually deliver durable outcomes.
This guide breaks down the real-world gap between clinical trial results and what employers are seeing on the ground, including the hidden costs of poor adherence, muscle loss, and weight regain. You'll also get a clear framework for structuring your GLP-1 approach, whether you cover the medications or not.
Download this resource to explore how leading employers are creating dual-path programs that support every employee and protect long-term ROI.
